Morales, DL, Zafar, F, Rossano, JW, et al. Use of ventricular assist devices in children across the United States: analysis of 7.5 million pediatric hospitalizations. Ann Thorac Surg
2010; 90: 1313–1318; discussion 8–9.
Fong, MW, Grazette, L, Cesario, D, Cao, M, Saxon, L. Treatment of ventricular tachycardia in patients with heart failure. Curr Cardiol Rep
2011; 13: 203–209.
Maskin, CS, Siskind, SJ, LeJemtel, TH. High prevalence of nonsustained ventricular tachycardia in severe congestive heart failure. Am Heart J
1984; 107 (5 Pt 1): 896–901.
Boyle, A. Arrhythmias in patients with ventricular assist devices. Curr Opin Cardiol
2012; 27: 13–18.
Pettit, SJ, Petrie, MC, Connelly, DT, et al. Use of implantable cardioverter defibrillators in patients with left ventricular assist devices. Eur J Heart Fail
2012; 14: 696–702.
Allen, SJ, Sidebotham, D. Postoperative care and complications after ventricular assist device implantation. Best Pract Res Clin Anaesthesiol
2012; 26: 231–246.
Ziv, O, Dizon, J, Thosani, A, Naka, Y, Magnano, AR, Garan, H. Effects of left ventricular assist device therapy on ventricular arrhythmias. J Am Coll Cardiol
2005; 45: 1428–1434.
Andersen, M, Videbaek, R, Boesgaard, S, Sander, K, Hansen, PB, Gustafsson, F. Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II). J Heart Lung Transplant
2009; 28: 733–735.
Brenyo, A, Rao, M, Koneru, S, et al. Risk of mortality for ventricular arrhythmia in ambulatory LVAD patients. J Cardiovasc Electrophysiol
2012; 23: 515–520.
Raasch, H, Jensen, BC, Chang, PP, et al. Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation. Am Heart J
2012; 164: 373–378.
Arai, H, Swartz, MT, Pennington, DG, et al. Importance of ventricular arrhythmias in bridge patients with ventricular assist devices. ASAIO Trans
1991; 37: M427–M428.
Fasseas, P, Kutalek, SP, Samuels, FL, Holmes, EC, Samuels, LE. Ventricular assist device support for management of sustained ventricular arrhythmias. Tex Heart Inst J
2002; 29: 33–36.
Tatewaki, H, Masuda, M, Nishida, T, et al. Successful treatment of tachycardia-induced cardiomyopathy with LVAD in a 12-year-old boy. Ann Thorac Surg
2005; 80: e5–e7.
Lakdawala, NK, Givertz, MM. Dilated cardiomyopathy with conduction disease and arrhythmia. Circulation
2010; 122: 527–534.
Scott, CD, Dark, JH, McComb, JM. Arrhythmias after cardiac transplantation. Am J Cardiol
1992; 70: 1061–1063.
Kuhl, U, Pauschinger, M, Seeberg, B, et al. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation
2005; 112: 1965–1970.
Blauwet, LA, Cooper, LT. Myocarditis. Prog Cardiovasc Dis
2010; 52: 274–288.
Kirk, R, Naftel, D, Hoffman, TM, et al. Outcome of pediatric patients with dilated cardiomyopathy listed for transplant: a multi-institutional study. J Heart Lung Transplant
2009; 28: 1322–1328.
Gajarski, R, Naftel, DC, Pahl, E, et al. Outcomes of pediatric patients with hypertrophic cardiomyopathy listed for transplant. J Heart Lung Transplant
2009; 28: 1329–1334.
Oz, MC, Rose, EA, Slater, J, Kuiper, JJ, Catanese, KA, Levin, HR. Malignant ventricular arrhythmias are well tolerated in patients receiving long-term left ventricular assist devices. J Am Coll Cardiol
1994; 24: 1688–1691.
Hall, JL, Fermin, DR, Birks, EJ, et al. Clinical, molecular, and genomic changes in response to a left ventricular assist device. J Am Coll Cardiol
2011; 57: 641–652.
Klotz, S, Danser, AH, Foronjy, RF, et al. The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure. J Am Coll Cardiol
2007; 49: 1166–1174.